Compare LBRDK & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LBRDK | SNN |
|---|---|---|
| Founded | 2014 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Industrial Specialties |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 14.0B |
| IPO Year | N/A | 1999 |
| Metric | LBRDK | SNN |
|---|---|---|
| Price | $47.51 | $33.43 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | ★ 1.2M | 476.9K |
| Earning Date | 11-05-2025 | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | 1.38 | ★ 59.91 |
| EPS | ★ 5.51 | 0.56 |
| Revenue | $1,016,000,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $8.37 | $7.78 |
| Revenue Next Year | $2.91 | $5.13 |
| P/E Ratio | ★ $5.70 | $29.10 |
| Revenue Growth | ★ 306.40 | 5.35 |
| 52 Week Low | $44.63 | $23.69 |
| 52 Week High | $104.00 | $38.79 |
| Indicator | LBRDK | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 48.01 |
| Support Level | $44.88 | $32.68 |
| Resistance Level | $46.77 | $33.56 |
| Average True Range (ATR) | 1.42 | 0.41 |
| MACD | 0.54 | 0.14 |
| Stochastic Oscillator | 82.05 | 78.51 |
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.